Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Recro Pharma Inks Development and Mfg. Pact | Contract Pharma

What are you searching for?

Sign in
Breaking News

Recro Pharma Inks Development and Mfg. Pact

To support a client’s ongoing clinical development of an orally administered, minimally-absorbed investigational compound.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Recro Pharma, Inc., a CDMO dedicated to solving complex formulation and manufacturing challenges for oral solid dose drugs, has signed a development and cGMP manufacturing agreement with a new client to provide early-stage development and manufacturing services to support the client’s ongoing clinical development of an orally administered, minimally-absorbed investigational compound.

“The opportunity to support our new client’s clinical development of its novel therapeutic candidate allows Recro to further highlight our unique expertise in implementing sophisticated solutions to solve complex formulation and manufacturing problems,” said David Enloe, president and chief executive officer of Recro.  “This agreement continues the momentum that we have generated by leveraging our decades-long experience in robust commercial GMP manufacturing for clinical-stage programs. We are excited to have been selected for this important work and look forward to a long and productive partnership.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics